Risk Factors for Long-term Body Weight Loss After Proximal Gastrectomy : A Retrospective Analysis
Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..
BACKGROUND/AIM: Proximal gastrectomy (PG) is a therapy for early-stage proximal gastric cancer and offers advantages such as the preservation of food storage capacity and less body weight loss (BWL). Nevertheless, significant BWL following PG may occur, affecting the patient's well-being and survival. In this study, we aimed to identify the relevant factors for BWL following PG by analyzing an institutional database of patients.
PATIENTS AND METHODS: We enrolled 58 consecutive patients who underwent PG for gastric or esophagogastric junction cancer at our institution between April 2004 and March 2021. Based on BWL at 12 months postoperatively, we retrospectively compared and examined patient characteristics, surgical details, and nutritional markers.
RESULTS: The mean BWL of the 58 patients included in this analysis was 14.0±7.2%. When the patients were divided into BWL-moderate (n=29) and BWL-severe (n=29) groups using a cutoff value of 15.7%, the latter experienced early BWL within 1 month postoperatively, primarily due to body fat mass reduction, with no recovery during the 60 months of follow up. In contrast, gradual recovery was observed among patients in the BWL-moderate group after experiencing the lowest body weight 24 months postoperatively. A greater decrease in body fat mass than in muscle mass was observed in both groups. Blood hemoglobin levels did not recover in the BWL-severe group.
CONCLUSION: The BWL-severe group after proximal gastrectomy demonstrated significantly greater early postoperative BWL, primarily attributed to a reduction in body fat mass, with hardly any recovery. Early postoperative nutritional intervention might be proposed to prevent long-term BWL.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Anticancer research - 44(2024), 4 vom: 27. März, Seite 1645-1651 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Agatsuma, Yuya [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Body weight loss |
|---|
| Anmerkungen: |
Date Completed 29.03.2024 Date Revised 29.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.21873/anticanres.16963 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370275128 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370275128 | ||
| 003 | DE-627 | ||
| 005 | 20240330001852.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240329s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21873/anticanres.16963 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM370275128 | ||
| 035 | |a (NLM)38537968 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Agatsuma, Yuya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk Factors for Long-term Body Weight Loss After Proximal Gastrectomy |b A Retrospective Analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.03.2024 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. | ||
| 520 | |a BACKGROUND/AIM: Proximal gastrectomy (PG) is a therapy for early-stage proximal gastric cancer and offers advantages such as the preservation of food storage capacity and less body weight loss (BWL). Nevertheless, significant BWL following PG may occur, affecting the patient's well-being and survival. In this study, we aimed to identify the relevant factors for BWL following PG by analyzing an institutional database of patients | ||
| 520 | |a PATIENTS AND METHODS: We enrolled 58 consecutive patients who underwent PG for gastric or esophagogastric junction cancer at our institution between April 2004 and March 2021. Based on BWL at 12 months postoperatively, we retrospectively compared and examined patient characteristics, surgical details, and nutritional markers | ||
| 520 | |a RESULTS: The mean BWL of the 58 patients included in this analysis was 14.0±7.2%. When the patients were divided into BWL-moderate (n=29) and BWL-severe (n=29) groups using a cutoff value of 15.7%, the latter experienced early BWL within 1 month postoperatively, primarily due to body fat mass reduction, with no recovery during the 60 months of follow up. In contrast, gradual recovery was observed among patients in the BWL-moderate group after experiencing the lowest body weight 24 months postoperatively. A greater decrease in body fat mass than in muscle mass was observed in both groups. Blood hemoglobin levels did not recover in the BWL-severe group | ||
| 520 | |a CONCLUSION: The BWL-severe group after proximal gastrectomy demonstrated significantly greater early postoperative BWL, primarily attributed to a reduction in body fat mass, with hardly any recovery. Early postoperative nutritional intervention might be proposed to prevent long-term BWL | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a body weight loss | |
| 650 | 4 | |a long-term outcome | |
| 650 | 4 | |a proximal gastrectomy | |
| 700 | 1 | |a Nakanishi, Koki |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, Chie |e verfasserin |4 aut | |
| 700 | 1 | |a Kanda, Mitsuro |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Dai |e verfasserin |4 aut | |
| 700 | 1 | |a Umeda, Shinichi |e verfasserin |4 aut | |
| 700 | 1 | |a Kurimoto, Keisuke |e verfasserin |4 aut | |
| 700 | 1 | |a Inokawa, Yoshikuni |e verfasserin |4 aut | |
| 700 | 1 | |a Takami, Hideki |e verfasserin |4 aut | |
| 700 | 1 | |a Hattori, Norifumi |e verfasserin |4 aut | |
| 700 | 1 | |a Hayashi, Masamichi |e verfasserin |4 aut | |
| 700 | 1 | |a Nakayama, Goro |e verfasserin |4 aut | |
| 700 | 1 | |a Fujiwara, Michitaka |e verfasserin |4 aut | |
| 700 | 1 | |a Kodera, Yasuhiro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anticancer research |d 1987 |g 44(2024), 4 vom: 27. März, Seite 1645-1651 |w (DE-627)NLM012601454 |x 1791-7530 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2024 |g number:4 |g day:27 |g month:03 |g pages:1645-1651 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21873/anticanres.16963 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2024 |e 4 |b 27 |c 03 |h 1645-1651 | ||